Open AccessP613: TLR9 SIGNALLING IS A POTENTIAL TUMOUR ESCAPE MECHANISM FOLLOWING BTKI THERAPY FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA.
Author(s) -
Kennedy E.,
Mitchell S.,
Burley T. A.,
Liloglou T.,
Johnston R.,
Ashworth I.,
BakBlaz D.,
Chamberlain K.,
Ladikou E.,
Mackay S.,
Pepper C.,
Pepper A. G.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845340.78869.11
Subject(s) - tlr9 , ighv@ , ibrutinib , toll like receptor 9 , breakpoint cluster region , cancer research , chronic lymphocytic leukemia , receptor , immunology , biology , medicine , leukemia , dna methylation , genetics , gene expression , gene